Home | Welcome to Contract Pharma   
Last Updated Friday, August 1 2014
Print

Breaking News

April 4, 2012
Will offer biomarker identification services  Read More »
April 4, 2012
XmAb platform delivers another candidate for clinical development  Read More »
April 4, 2012
Phase III program in postmenopausal osteoporosis underway  Read More »
April 3, 2012
Ridinger elected at board meeting  Read More »
April 3, 2012
Toride site adds cold chain capability to Japan portfolio  Read More »
April 3, 2012
Bessor Pharma has option to take over R&D  Read More »
April 3, 2012
Will jointly develop and commercialize five Amgen monoclonal antibodies  Read More »
April 3, 2012
Manchester services include comprehensive characterization for biologics  Read More »
April 3, 2012
Expands buffer production capacity, increases raw materials portfolio  Read More »
April 2, 2012
Clinical grant spending and activity increase  Read More »
April 2, 2012
Spends $213 million to boost ownership to 27%  Read More »
April 2, 2012
FDA approves IND for Phase I Nanobody  Read More »
April 2, 2012
Integrates Laboratorio Hidalgo’s testing platforms  Read More »
March 30, 2012
Billingham, UK site adds new equipment, increases workforce  Read More »
March 30, 2012
Adds new filling area at German facility  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On